Axena Health, a Newton, MA-based medical device company specializing in female pelvic health, has successfully closed an additional $9.4 million in its Series A funding round.
Key Highlights:
- Funding Amount: $9.4 million in additional Series A funding.
- Lead Investor: Cross-Border Impact Ventures (CBIV).
- Other Participants: Existing investors include AXA IM Alts through its Global Healthcare Private Equity Strategy, KOFA Healthcare, and Avestria Ventures.
- Board Addition: Donna Parr, Managing Director and Partner at CBIV, will join Axena Health’s board of directors as part of the investment.
Company Overview:
- CEO: Jim O’Connor.
- Location: Newton, MA.
- Core Focus: Axena Health is committed to improving the lives of women with pelvic floor disorders through innovative medical devices.
Flagship Product:
- Leva® Pelvic Health System: This system provides a non-invasive, drug-free first-line treatment for urinary incontinence (UI) and chronic fecal incontinence (FI), conditions that affect over 78 million and 12 million women in the U.S., respectively. The Leva® system offers precise visualization of pelvic floor muscle movements in real time, facilitating effective pelvic floor muscle training while monitoring usage and progress.
Use of Funds:
- Expansion and Development: The additional funds will be used to expand Axena Health’s product offerings and further its development efforts, aiming to provide more comprehensive solutions for women with pelvic floor disorders.
Statements from Leadership:
- Donna Parr, Managing Director and Partner at CBIV: Expressed enthusiasm about joining the board and supporting Axena Health’s mission to improve women’s health through innovative medical technology.
Conclusion
Axena Health’s successful closing of an additional $9.4 million in Series A funding highlights the significance of its mission to address pelvic floor disorders in women. With this new capital, the company is poised to expand its product offerings and continue developing cutting-edge solutions to enhance the quality of life for millions of women.
